How has been the historical performance of Quick Heal Tech?

Oct 16 2025 10:42 PM IST
share
Share Via
Quick Heal Tech has experienced declining financial performance, with net sales dropping from INR 341.90 crore in March 2022 to INR 279.53 crore in March 2025, and a significant decrease in profitability, leading to a negative operating profit of -6.59 crore in March 2025. Total assets also fell from INR 826.69 crore in March 2021 to INR 517.10 crore in March 2025, indicating a tightening financial position.
Answer:
The historical performance of Quick Heal Tech shows a fluctuating trend in key financial metrics over the years.

Breakdown:
Quick Heal Tech's net sales have seen a decline from INR 341.90 crore in March 2022 to INR 279.53 crore in March 2025, with a slight recovery from INR 278.09 crore in March 2023. The total operating income followed a similar pattern, peaking at INR 341.90 crore in March 2022 and dropping to INR 279.53 crore by March 2025. The company has faced increasing total expenditures, which rose from INR 187.02 crore in March 2019 to INR 286.12 crore in March 2025, contributing to an operating profit that turned negative at -6.59 crore in March 2025, down from a high of INR 165.62 crore in March 2021. Profit before tax also decreased significantly, from INR 146.14 crore in March 2021 to just INR 1.00 crore in March 2025. Consequently, profit after tax fell sharply from INR 106.98 crore in March 2021 to INR 5.04 crore in March 2025. The earnings per share (EPS) reflected this decline, dropping from INR 16.66 in March 2021 to INR 0.93 in March 2025. On the balance sheet, total assets decreased from INR 826.69 crore in March 2021 to INR 517.10 crore in March 2025, while total liabilities also rose slightly, indicating a tightening financial position. Cash flow from operating activities turned negative at -22.00 crore in March 2025, contrasting with positive cash flows in previous years. Overall, Quick Heal Tech's financial performance has shown significant challenges, particularly in profitability and cash flow, over the recent years.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News